Project Number 5R01AG065387-02 Agency/Funding Organization NIA Funding Year 2021 View Full Project Details for Development of STEP Allosteric Inhibitors as Novel Therapeutics for Alzheimer's Disease Research Categorization Primary Disease / Condition Alzheimer's Disease CADRO Category C. Translational Research and Clinical Interventions 3. Drug Discovery (small molecules and biologics) m. Synaptic Plasticity/Neuroprotection Researcher and Organization Principal Investigator TAUTZ, LUTZ Principal Investigator First Name LUTZ Principal Investigator Last Name TAUTZ Awardee Organization SANFORD BURNHAM PREBYS MEDICAL DISCOVERY INSTITUTE Awardee State California Contact PI Country United States Project Detail Funding Opportunity Announcement PAR-19-147: Drug Discovery For Nervous System Disorders (R01 Clinical Trials Not Allowed) FY Overall Cost $902,529 Funding Organization Agency/Funding Organization NIA Funding Organization Country United States Program Official REFOLO, LORENZO
